Copart Inc (CPRT) shareholders
Close on Nov 17, 2026Market cap $29.13BP/E 20.3Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Vanguard Capital Management | 66,093,193 | 6.86% | 13G (passive) | Mar 31, 2026 |
| BlackRock, Inc. | 58,210,940 | 6.00% | 13G (passive) amendment | Mar 31, 2025 |
| Willis J. Johnson | 55,684,212 | 5.78% | 13G (passive) amendment | Oct 31, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CPRT | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 67,718,347 | 7.31% | $1.91B | +4,391,355 | 0.03% |
| Vanguard Capital Management LLC | 57,331,249 | 6.19% | $1.62B | +56,033 | 0.03% |
| State Street Corp | 38,827,400 | 4.19% | $1.09B | +691,330 | 0.03% |
| Vanguard Portfolio Management LLC | 38,736,327 | 4.18% | $1.09B | −2,662,762 | 0.05% |
| Invesco Ltd. | 33,018,576 | 3.56% | $930.79M | +783,161 | 0.07% |
| Geode Capital Management, LLC | 27,397,980 | 2.96% | $769.69M | +3,175,077 | 0.04% |
| Bank of New York Mellon Corp | 17,334,626 | 1.87% | $488.66M | −3,142,502 | 0.08% |
| Morgan Stanley | 16,070,099 | 1.73% | $453.02M | +1,579,868 | 0.02% |
| Capital World Investors | 15,689,549 | 1.69% | $442.28M | −2,497,019 | 0.05% |
| Deutsche Bank AG\ | 15,481,141 | 1.67% | $436.41M | +4,607,957 | 0.13% |
| Norges Bank | 14,424,810 | 1.56% | $406.64M | New | 0.04% |
| Aqr Capital Management LLC | 14,020,624 | 1.51% | $395.24M | +4,570,770 | 0.14% |
| Two Sigma Investments, LP | 12,549,718 | 1.35% | $353.78M | +1,841,683 | 0.26% |
| Nuveen, LLC | 9,399,426 | 1.01% | $264.97M | −313,343 | 0.06% |
| Van Eck Associates Corp | 9,059,273 | 0.98% | $255.38M | +4,482,226 | 0.16% |
| Goldman Sachs Group Inc | 8,445,143 | 0.91% | $238.07M | +225,453 | 0.02% |
| Northern Trust Corp | 8,239,958 | 0.89% | $232.28M | −393,111 | 0.03% |
| Akre Capital Management LLC | 7,985,808 | 0.86% | $225.12M | −13,130 | 4.39% |
| Fiera Capital Corp | 7,958,741 | 0.86% | $224.36M | −1,053,506 | 0.81% |
| PineStone Asset Management Inc. | 7,913,707 | 0.85% | $223.09M | −436,300 | 1.38% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1,058 | 788M | 85.1% | 130 / 402 | 402 / 139 | 114M | 91M |
| Q1 2026 | 1,082 | 766M | 82.7% | 124 / 407 | 420 / 161 | 178M | 113M |
| Q4 2025 | 1,141 | 812M | 87.6% | 172 / 394 | 447 / 156 | 124M | 101M |
| Q3 2025 | 1,147 | 794M | 85.7% | 111 / 472 | 411 / 132 | 72M | 86M |
| Q2 2025 | 1,188 | 809M | 87.3% | 126 / 448 | 472 / 118 | 70M | 66M |
| Q1 2025 | 1,195 | 806M | 87.0% | 133 / 500 | 392 / 89 | 58M | 38M |
| Q4 2024 | 1,170 | 797M | 86.1% | 170 / 438 | 421 / 71 | 55M | 53M |
| Q3 2024 | 1,087 | 798M | 86.1% | 112 / 446 | 394 / 85 | 113M | 45M |
| Q2 2024 | 1,073 | 799M | 86.3% | 103 / 432 | 390 / 87 | 47M | 73M |
| Q1 2024 | 1,070 | 831M | 89.7% | 126 / 419 | 379 / 90 | 73M | 38M |
| Q4 2023 | 1,047 | 797M | 86.0% | 156 / 382 | 378 / 75 | 68M | 31M |
| Q3 2023 | 983 | 762M | 82.2% | 93 / 363 | 391 / 68 | 28M | 35M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
736 funds held CPRT in Q2 2026, 54% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of CPRT | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 27,527,711 | 2.97% | $776.01M | 0.03% | Jun 30, 2026 |
| Vanguard 500 Index Fund | 22,962,864 | 2.48% | $647.32M | 0.04% | Jun 30, 2026 |
| Invesco QQQ Trust, Series 1 | 19,652,369 | 2.12% | $554.00M | 0.11% | Jun 30, 2026 |
| Vanguard Mid-Cap Index Fund | 18,786,028 | 2.03% | $529.58M | 0.24% | Jun 30, 2026 |
| iShares Core S&P 500 ETF | 12,190,378 | 1.32% | $343.65M | 0.04% | Jun 30, 2026 |
| Fidelity 500 Index Fund | 11,396,748 | 1.23% | $373.47M | 0.04% | May 31, 2026 |
| New Perspective Fund | 8,495,553 | 0.92% | $239.49M | 0.14% | Jun 30, 2026 |
| VanEck Morningstar Wide Moat ETF | 8,288,344 | 0.89% | $233.65M | 2.01% | Jun 30, 2026 |
| Vanguard Value Index Fund | 8,281,249 | 0.89% | $233.45M | 0.09% | Jun 30, 2026 |
| Akre Focus ETF | 7,000,000 | 0.76% | $203.84M | 3.88% | Jul 31, 2026 |
| Vanguard Mid-Cap Growth Index Fund | 6,642,341 | 0.72% | $187.25M | 0.54% | Jun 30, 2026 |
| Invesco S&P 500 Equal Weight ETF | 5,942,032 | 0.64% | $173.03M | 0.18% | Jul 31, 2026 |
| State Street(R) Industrial Select Sector SPDR(R) ETF | 5,235,335 | 0.57% | $147.58M | 0.43% | Jun 30, 2026 |
| Vanguard Institutional Index Fund | 4,811,587 | 0.52% | $135.64M | 0.04% | Jun 30, 2026 |
| First Trust Capital Strength ETF | 4,604,917 | 0.50% | $129.81M | 1.70% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Willis J. Johnson | Chairman of the Board, Director | 99,862,655 | 10.78% | Oct 21, 2026 |
| A. Jayson Adair | Executive Chairman, Director | 26,511,571 | 2.86% | Jan 22, 2026 |
| Jane Pocock | President | 330 | 0.00% | Aug 18, 2026 |
| Leah C. Stearns | Chief Financial Officer | – | – | Aug 18, 2026 |
| Jeffrey Liaw | Chief Executive Officer | 84,220 | 0.01% | Jul 30, 2026 |
| Diane M. Morefield | Director | 70,000 | 0.01% | Oct 19, 2026 |
| David Joel Berger | Director | – | – | Aug 17, 2026 |
| Daniel J. Englander | Director | 610,704 | 0.07% | Jul 15, 2026 |
| Thomas N. Tryforos | Director | 513,785 | 0.06% | Dec 31, 2025 |
| Matt Blunt | Director | 50,000 | 0.01% | Dec 9, 2025 |
| Stephen Fisher | Director | 160,000 | 0.02% | Dec 9, 2025 |
| Cherylyn Harley LeBon | Director | – | – | Dec 9, 2025 |
| Carl Sparks | Director | – | – | Dec 9, 2025 |
| Steven D. Cohan | Director | 95,021 | 0.01% | Dec 9, 2025 |
| James E. Meeks | Director | 6,254 | 0.00% | Dec 9, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Diane M. Morefield Director | Oct 15, 2026 | Sale | −20,000 | $27.66 | $553.20K | 50,000 |
| Willis J. Johnson Chairman of the Board, Director | Oct 9, 2026 | Other | +3,090,000 | – | – | 3,090,000 |
| Willis J. Johnson Chairman of the Board, Director | Oct 9, 2026 | Other | −3,090,000 | – | – | 44,502,321 |
| Willis J. Johnson Chairman of the Board, Director | Oct 9, 2026 | Other | −3,090,000 | – | – | 47,592,321 |
| Jeffrey Liaw Chief Executive Officer | Jul 28, 2026 | Option exercise | +3,591 | $6.78 | $24.35K | 84,220 |
| Jeffrey Liaw Chief Executive Officer | Jul 28, 2026 | Option exercise | +43,166 | $8.70 | $375.54K | 127,386 |
| Jeffrey Liaw Chief Executive Officer | Jul 28, 2026 | Sale(10b5-1 plan) | −27,745 | $30.49 | $845.95K | 99,641 |
| Jeffrey Liaw Chief Executive Officer | Jul 15, 2026 | Option exercise | +812 | $8.70 | $7.06K | 81,621 |
| Jeffrey Liaw Chief Executive Officer | Jul 15, 2026 | Option exercise | +1,277 | $6.78 | $8.66K | 80,809 |
| Daniel J. Englander Director | Jul 13, 2026 | Other | −40,000 | – | – | 235,352 |
| Daniel J. Englander Director | Jul 13, 2026 | Sale | −80,000 | $27.55 | $2.20M | 275,352 |
| Diane M. Morefield Director | Jul 8, 2026 | Option exercise | +50,000 | $19.78 | $989.00K | 50,000 |
| Jeffrey Liaw Chief Executive Officer | Apr 15, 2026 | Option exercise | +43,166 | $8.70 | $375.54K | 103,659 |
| Jeffrey Liaw Chief Executive Officer | Apr 15, 2026 | Option exercise | +809 | $6.78 | $5.49K | 104,468 |
| Jeffrey Liaw Chief Executive Officer | Apr 15, 2026 | Option exercise | +1,277 | $8.70 | $11.11K | 105,745 |
| Jeffrey Liaw Chief Executive Officer | Apr 15, 2026 | Sale(10b5-1 plan) | −2,343 | $33.17 | $77.72K | 79,532 |
| Jeffrey Liaw Chief Executive Officer | Apr 15, 2026 | Sale(10b5-1 plan) | −23,870 | $33.18 | $792.01K | 81,875 |
| Jeffrey Liaw Chief Executive Officer | Apr 15, 2026 | Option exercise | +4,523 | $6.78 | $30.67K | 60,493 |
| A. Jayson Adair Executive Chairman, Director | Jan 20, 2026 | Gift | −21,200 | – | – | 254,400 |
| A. Jayson Adair Executive Chairman, Director | Jan 20, 2026 | Gift | −21,200 | – | – | 318,000 |
| A. Jayson Adair Executive Chairman, Director | Jan 20, 2026 | Gift | −7,761 | – | – | 14,174,859 |
| Jeffrey Liaw Chief Executive Officer | Jan 15, 2026 | Option exercise | +1,277 | $8.70 | $11.11K | 81,107 |
| Jeffrey Liaw Chief Executive Officer | Jan 15, 2026 | Sale(10b5-1 plan) | −22,693 | $40.17 | $911.58K | 55,970 |
| Jeffrey Liaw Chief Executive Officer | Jan 15, 2026 | Sale(10b5-1 plan) | −2,444 | $40.17 | $98.18K | 78,663 |
| Jeffrey Liaw Chief Executive Officer | Jan 15, 2026 | Option exercise | +4,523 | $6.78 | $30.67K | 35,855 |
| Jeffrey Liaw Chief Executive Officer | Jan 15, 2026 | Option exercise | +43,166 | $8.70 | $375.54K | 79,021 |
| Jeffrey Liaw Chief Executive Officer | Jan 15, 2026 | Option exercise | +809 | $6.78 | $5.49K | 79,830 |
| Thomas N. Tryforos Director | Dec 30, 2025 | Gift | −27,850 | – | – | 413,785 |
| Thomas N. Tryforos Director | Dec 30, 2025 | Gift | +27,850 | – | – | 27,850 |
| Willis J. Johnson Chairman of the Board, Director | Dec 10, 2025 | Gift | −129,200 | – | – | 1,130,349 |
| Thomas N. Tryforos Director | Nov 25, 2025 | Option exercise | +100,000 | $11.80 | $1.18M | 100,000 |
| Thomas N. Tryforos Director | Nov 25, 2025 | Sale | −100,000 | $39.07 | $3.91M | 0 |
| Daniel J. Englander Director | Nov 13, 2025 | Option exercise | +100,000 | $11.80 | $1.18M | 100,000 |
| Jeffrey Liaw Chief Executive Officer | Oct 15, 2025 | Option exercise | +1,277 | $8.70 | $11.11K | 7,926 |
| Jeffrey Liaw Chief Executive Officer | Oct 15, 2025 | Option exercise | +43,166 | $8.70 | $375.54K | 55,615 |
| Jeffrey Liaw Chief Executive Officer | Oct 15, 2025 | Option exercise | +809 | $6.78 | $5.49K | 6,649 |
| Jeffrey Liaw Chief Executive Officer | Oct 15, 2025 | Option exercise | +4,523 | $6.78 | $30.67K | 12,449 |
| Jeffrey Liaw Chief Executive Officer | Oct 15, 2025 | Sale(10b5-1 plan) | −22,086 | $44.79 | $989.23K | 31,332 |
| Jeffrey Liaw Chief Executive Officer | Oct 15, 2025 | Sale(10b5-1 plan) | −2,197 | $44.80 | $98.43K | 53,418 |
| Thomas N. Tryforos Director | Sep 15, 2025 | Option exercise | +228,840 | $4.91 | $1.12M | 228,840 |
| Thomas N. Tryforos Director | Sep 15, 2025 | Sale | −228,840 | $47.54 | $10.88M | 0 |
| Jeffrey Liaw Chief Executive Officer, Director | Jul 15, 2025 | Option exercise | +4,523 | $6.78 | $30.67K | 10,363 |
| Jeffrey Liaw Chief Executive Officer, Director | Jul 15, 2025 | Option exercise | +43,166 | $8.70 | $375.54K | 53,529 |
| Jeffrey Liaw Chief Executive Officer, Director | Jul 15, 2025 | Option exercise | +809 | $6.78 | $5.49K | 54,338 |
| Jeffrey Liaw Chief Executive Officer, Director | Jul 15, 2025 | Option exercise | +1,277 | $8.70 | $11.11K | 55,615 |
| Jeffrey Liaw Chief Executive Officer, Director | Jul 15, 2025 | Sale(10b5-1 plan) | −1,884 | $46.35 | $87.32K | 53,731 |
| Jeffrey Liaw Chief Executive Officer, Director | Jul 15, 2025 | Sale(10b5-1 plan) | −300 | $46.90 | $14.07K | 53,431 |
| Jeffrey Liaw Chief Executive Officer, Director | Jul 15, 2025 | Sale(10b5-1 plan) | −3,616 | $46.84 | $169.37K | 31,527 |
| Jeffrey Liaw Chief Executive Officer, Director | Jul 15, 2025 | Sale(10b5-1 plan) | −18,288 | $46.35 | $847.65K | 35,143 |
| Steven D. Cohan Director | Apr 14, 2025 | Option exercise | +94,997 | $11.80 | $1.12M | 94,997 |
| Steven D. Cohan Director | Apr 14, 2025 | Sale | −94,997 | $60.01 | $5.70M | 0 |
| Steven D. Cohan Director | Apr 11, 2025 | Sale | −5,003 | $60.01 | $300.23K | 0 |
| Steven D. Cohan Director | Apr 11, 2025 | Option exercise | +5,003 | $11.80 | $59.04K | 5,003 |
| James E. Meeks Director | Mar 19, 2025 | Sale | −100,000 | $54.00 | $5.40M | 0 |
| James E. Meeks Director | Mar 19, 2025 | Option exercise | +100,000 | $11.80 | $1.18M | 100,000 |
| Diane M. Morefield Director | Jan 10, 2025 | Gift | +20,000 | – | – | 20,000 |
| Diane M. Morefield Director | Jan 10, 2025 | Gift | −20,000 | – | – | 0 |
| A. Jayson Adair Executive Chairman, Director | Jan 6, 2025 | Gift | −21,200 | – | – | 339,200 |
| A. Jayson Adair Executive Chairman, Director | Jan 6, 2025 | Gift | −5,360 | – | – | 14,182,620 |
| A. Jayson Adair Executive Chairman, Director | Jan 6, 2025 | Gift | −21,200 | – | – | 275,600 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Copart's stock actually held short. Settlement fails (shares not delivered on time) peaked at 397,781 shares on Oct 13, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Diane M. Morefield Director | Oct 15, 2026 | 20,000 | $551.29K | Oct 15, 2026 | Stock Option Exercise |
| Jeff Liaw Officer | Jul 28, 2026 | 27,745 | $826.52K | Jul 28, 2026 | Exercise of Stock Options |
| Ursula Capital Partners LP Director | Jul 13, 2026 | 80,000 | $2.20M | Jul 13, 2026 | Open Market Purchase |
| Jeffrey Liaw Officer | Apr 15, 2026 | 26,213 | $872.63K | Apr 15, 2026 | Exercise of Stock Options |
| Jeffrey Liaw Officer | Jan 15, 2026 | 25,137 | $1.01M | Jan 15, 2026 | Exercise of Stock Options |
| Thomas N. Tryforos Director | Nov 25, 2025 | 100,000 | $3.91M | Nov 25, 2025 | Stock Option Exercise |
| Jeffrey Liaw Director, Officer | Oct 15, 2025 | 24,283 | $1.09M | Oct 15, 2025 | Exercise of Stock Options |
| Thomas N. Tryforos Director | Sep 15, 2025 | 228,840 | $10.88M | Sep 15, 2025 | Stock Option Exercise |
| Jeffrey Liaw Officer | Jul 15, 2025 | 24,088 | $1.14M | Jul 15, 2025 | Exercise of Stock Options |
| Steven D. Cohan Director | Apr 11, 2025 | 100,000 | $6.00M | Apr 11, 2025 | Exercised Stock Options |
| James E. Meeks Director | Mar 19, 2025 | 100,000 | $5.40M | Mar 19, 2025 | STOCK OPTION EXERCISE |
| James E. Meeks Director | Feb 28, 2025 | 100,000 | $5.68M | Feb 28, 2025 | STOCK OPTION EXERCISE |
| Daniel J. Englander Director | Jan 3, 2025 | 320,000 | $18.26M | Jan 3, 2024 | STOCK OPTION EXERCISE |
| Matt Blunt Director | Jan 2, 2025 | 50,000 | $2.88M | Jan 2, 2025 | STOCK OPTION EXERCISE |
| Diane M. Morefield Director | Dec 23, 2024 | 30,000 | $1.74M | Dec 23, 2024 | STOCK OPTION EXERCISE |
Congress trades
10 trades in Copart reported by 5 members of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Valerie Hoyle OR04 · spouse | Sold | Aug 19, 2025 | $1K–15K | Sep 12, 2025 |
| Jefferson Shreve IN06 | Sold | May 12, 2025 | $15K–50K | Jun 22, 2025 |
| Valerie Hoyle OR04 · spouse | Bought | Oct 29, 2024 | $1K–15K | Sep 12, 2025 318 days late |
| Susie Lee NV03 · joint account | Sold | Feb 27, 2019 | $1K–15K | Mar 12, 2019 |
| Lamar Smith TX21 | Bought | Dec 19, 2018 | $1K–15K | Jan 10, 2019 |
| Thomas MacArthur NJ03 · joint account | Sold | Dec 7, 2018 | $15K | Jan 11, 2019 |
| Lamar Smith TX21 | Bought | Oct 24, 2018 | $1K–15K | Nov 8, 2018 |
| Lamar Smith TX21 | Bought | Oct 11, 2018 | $1K–15K | Nov 8, 2018 |
| Thomas MacArthur NJ03 · joint account | Bought | Jun 7, 2018 | $15K | Jul 10, 2018 |
| Lamar Smith TX21 | Bought | Feb 8, 2018 | $1K–15K | Mar 7, 2018 |
See a number that looks wrong?